On October 12, 2022, CANARIABIO Inc. closed the transaction. The company issued 1,457,655 shares for gross proceeds of KRW 29,999,997,555.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
412 KRW | +26.77% | -.--% | -64.17% |
May. 14 | Sejong Medical Co., Ltd. cancelled the transaction announced on November 7, 2022 | CI |
2023 | Sejong Medical Co., Ltd.(KOSDAQ:A258830) dropped from S&P Global BMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
-64.17% | 16.85M | |
+8.94% | 27.43B | |
-29.70% | 3.14B | |
+35.19% | 2.77B | |
-19.19% | 2.46B | |
+8.09% | 2.36B | |
+33.33% | 2.14B | |
-1.73% | 2.09B | |
+34.05% | 1.49B | |
+3.80% | 1.37B |
- Stock Market
- Equities
- A258830 Stock
- News Sejong Medical Co., Ltd.
- CANARIABIO Inc. announced that it has received KRW 29.999997555 billion in funding from Sejong Medical Co., Ltd.